Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.

Heparan sulfate proteoglycans (HSPG) are involved in the binding and uptake of apolipoprotein (apo) E-enriched remnant lipoproteins by cultured cells in vitro. To define the role of hepatic HSPG in remnant lipoprotein clearance in vivo, heparinase (30 units) was infused intravenously into mice to hydrolyze the liver HSPG and determine the effect of HSPG hydrolysis on remnant clearance by the liver. Liver HSPG were prelabeled by peritoneal injection of [35S]Na2SO4. Injection of heparinase decreased the amount of 35S-labeled liver HSPG by approximately 20-40% within 10-15 min. Heparinase infusion significantly inhibited the clearance of chylomicrons, chylomicron remnants, chylomicron remnants + apoE, rabbit beta-very low density lipoproteins (beta-VLDL), and beta-VLDL + apoE. Compared with saline injection in control mice, heparinase injection retarded the plasma clearance of the remnants by 1.5- to 2-fold and decreased liver uptake by 1.3- to 1.6-fold. Confocal fluorescence microscopy of thick slices of liver from mice injected with 1,1'-dioctadecyl-3,3,3', 3'-tetramethylindocarbocyanine-labeled beta-VLDL + apoE revealed markedly less intense fluorescence from hepatocytes in heparinase-treated animals compared with those in saline-treated control animals. Intravenous heparinase infusion did not inhibit the clearance of mouse low density lipoproteins (LDL), a ligand for the LDL receptor, and did not affect the clearance of alpha 2-macroglobulin, a ligand for the LDL receptor-related protein. The results suggest an important role of the liver HSPG in remnant clearance in vivo.

[1]  R. Mahley,et al.  Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[2]  J. Taylor,et al.  Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. , 1994, Journal of lipid research.

[3]  T. Willnow,et al.  Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. , 1994, Science.

[4]  J. Taylor,et al.  Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. , 1994, The Journal of biological chemistry.

[5]  R. Mahley,et al.  Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. , 1994, The Journal of biological chemistry.

[6]  Y. Yazaki,et al.  Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. , 1994, The Journal of clinical investigation.

[7]  S. Griglio,et al.  Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. , 1994, The Biochemical journal.

[8]  R. Havel,et al.  Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. , 1994, Journal of lipid research.

[9]  R. Mahley,et al.  Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. , 1994, The Journal of biological chemistry.

[10]  I. Warshawsky,et al.  39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. , 1993, The Journal of clinical investigation.

[11]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[12]  A. Schwartz,et al.  Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. , 1993, The Journal of biological chemistry.

[13]  R. Mahley,et al.  Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. , 1993, The Journal of biological chemistry.

[14]  R. Frants,et al.  Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. , 1993, The Journal of biological chemistry.

[15]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[16]  S. Eisenberg,et al.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. , 1992, The Journal of clinical investigation.

[17]  J. Sambrook,et al.  Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Moestrup,et al.  Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.

[19]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[20]  D. Strickland,et al.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. , 1992, The Journal of biological chemistry.

[21]  R. Frants,et al.  Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. , 1992, Biochemical and biophysical research communications.

[22]  T. V. van Berkel,et al.  Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. , 1992, The Journal of biological chemistry.

[23]  M. Klein,et al.  Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. , 1992, The Journal of clinical investigation.

[24]  M. Brown,et al.  39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.

[25]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Fong,et al.  Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. , 1991, The Journal of clinical investigation.

[27]  S. Newman,et al.  A rapid colorimetric assay for heparinase activity. , 1991, Analytical biochemistry.

[28]  S. Moestrup,et al.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.

[29]  R. Mahley,et al.  Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.

[30]  M. Farquhar,et al.  Characterization of a novel heparan sulfate proteoglycan found in the extracellular matrix of liver sinusoids and basement membranes , 1991, The Journal of cell biology.

[31]  R. Mahley,et al.  Chylomicron and chylomicron remnant catabolism , 1991 .

[32]  J. Goldstein,et al.  The low-density lipoprotein receptor-related protein: double agent or decoy? , 1991 .

[33]  M. Brown,et al.  Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. , 1990, The Journal of biological chemistry.

[34]  R. Havel,et al.  Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. , 1990, Journal of lipid research.

[35]  R. Mahley,et al.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. , 1990, The Journal of biological chemistry.

[36]  D. Strickland,et al.  The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin , 1990, The Journal of cell biology.

[37]  U. Beisiegel,et al.  The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein , 1989, Nature.

[38]  M. Brown,et al.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Mahley,et al.  Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. , 1989, The Journal of biological chemistry.

[40]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[41]  H. Goldenberg,et al.  Characteristics of chylomicron remnant uptake into rat liver. , 1988, Clinical biochemistry.

[42]  J. Stow,et al.  Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes , 1985, The Journal of cell biology.

[43]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[44]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[45]  J. Herz.  The LDL-receptor-related protein ??? portrait of a multifunctional receptor , 1993 .